Dexamethasone administration during definitive radiation and temozolomide renders a poor prognosis in a retrospective analysis of newly diagnosed glioblastoma patients
Crossref DOI link: https://doi.org/10.1186/s13014-015-0527-0
Published Online: 2015-10-31
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Shields, Lisa B. E.
Shelton, Brent J.
Shearer, Andrew J.
Chen, Li
Sun, David A.
Parsons, Sarah
Bourne, T. David
LaRocca, Renato
Spalding, Aaron C.
Funding for this research was provided by:
NCI grant (P30 CA177558)